Freestone Grove Partners LP Merck & Co., Inc. Transaction History
Freestone Grove Partners LP
- $9.71 Trillion
- Q1 2025
A detailed history of Freestone Grove Partners LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 10,977 shares of MRK stock, worth $836,118. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,977Holding current value
$836,118% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,893Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$15.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.18 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.22 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.54 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $193B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...